Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-valvular Atrial Fibrillation (NVAF)”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Not applicableStudy completedNCT05022758
What this trial is testing

Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 45,000
Not applicableStudy completedNCT02043808
What this trial is testing

The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 25,586
Not applicableStudy completedNCT01598051
What this trial is testing

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 741
Early research (Phase 1)Active Not RecruitingNCT06725355
What this trial is testing

To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
HK inno.N Corporation 60
Not applicableStudy completedNCT02954237
What this trial is testing

AMPLATZER™ Cardiac Plug Observational Post-Approval Study

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Abbott Medical Devices 91
Not applicableUnknownNCT03554837
What this trial is testing

Safety and Effectiveness of Low Dose Edoxaban in Patients With NVAF

Who this might be right for
Atrial Fibrillation
Samsung Medical Center 2,562
Not applicableStudy completedNCT05471505
What this trial is testing

Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 120,722
Not applicableStudy completedNCT02687867
What this trial is testing

Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 56,039
Testing effectiveness (Phase 2)Study completedNCT00938730
What this trial is testing

A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Astellas Pharma Inc 1,280
Not applicableStudy completedNCT02960880
What this trial is testing

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

Who this might be right for
Atrial Fibrillation
Bayer 99,999
Not applicableStudy completedNCT02502396
What this trial is testing

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Who this might be right for
CancerDeep-vein Thrombosis of the Lower and Upper ExtremitiesPulmonary Embolism+1 more
M.D. Anderson Cancer Center 265
Not applicableStudy completedNCT03247569
What this trial is testing

Edoxaban Treatment in Routine Clinical Practice for Patients With Non-Valvular Atrial Fibrillation (NVAF)

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo (Thailand) Ltd., a Daiichi Sankyo Company 300
Not applicableStudy completedNCT02687854
What this trial is testing

Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 18,591
Not applicableStudy completedNCT03746301
What this trial is testing

Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 924
Not applicableStudy completedNCT02485873
What this trial is testing

Real-Life Evidence on Stroke Prevention in SPAF

Who this might be right for
Atrial Fibrillation (Prevention of Stroke)
Bayer 8,607
Not applicableStudy completedNCT06606275
What this trial is testing

The Safety and Effectiveness of Warfarin Vs Apixaban in Patients with NVAF/ VTE and ESKD on Dialysis

Who this might be right for
End-Stage Kidney Disease (ESKD)Non-valvular Atrial Fibrillation (NVAF)Venous Thromboembolism (VTE)
Abu Dhabi Health Services Company 67
Not applicableEnrolling By InvitationNCT05560204
What this trial is testing

Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or Amulet

Who this might be right for
Combined Pulsed-field Ablation (PFA)
Prince of Wales Hospital, Shatin, Hong Kong 200
Not applicableUnknownNCT02356432
What this trial is testing

Cerebral Microbleeds During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW)

Who this might be right for
Ischemic StrokeAtrial Fibrillation Symptomatic
Tokai University 86
Not applicableNot Yet RecruitingNCT07396493
What this trial is testing

A Prospective, Single-arm Study Evaluating the Endothelialization Effect and Timeline of AnchorMan® Left Atrial Appendage Occluder in Non-valvular Atrial Fibrillation Patients at High Risk of Stroke

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)High Risk of Stroke
Shanghai Zhongshan Hospital 306
Not applicableLooking for participantsNCT04298723
What this trial is testing

Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.

Who this might be right for
Intracranial HemorrhagesAtrial Fibrillation (AF)Atrial Flutter
Jena University Hospital 530
Load More Results